|
|
||||||||
a Department of Cell Differentiation, Institute of Molecular Embryology and Genetics, Kumamoto University School of Medicine, Kumamoto, Japan;
b Department of Anatomy, Meikai University School of Dentistry, Saitama, Japan;
c Shionogi Research Laboratories, Osaka, Japan
Key Words. Osteoclasts • Tyro 3 • Gas6 • Bone resorption
Dr. Toshio Suda, Department of Cell Differentiation, Institute of Molecular Embryology and Genetics, Kumamoto University School of Medicine, 2-2-1, Honjo, Kumamoto 860-0811 Japan.
Bone is continuously being formed and resorbed. This process is accomplished by the precise coordination of two cell types: osteoblasts and osteoclasts. Osteoclasts are large, multinucleated cells that are derived from the same hematopoietic precursors as macrophages. However, these bone-resorbing cells are difficult to study directly because of their relative inaccessibility. The purification of primary osteoclasts from rabbit bones by their adherent nature provides an opportunity for investigating the molecules in osteoclasts. We have examined the expression of receptor tyrosine kinase by polymerase chain reaction (PCR) and found that Tyro 3 was frequently identified from primary osteoclasts in PCR cloning. Immunohistochemistry revealed that Tyro 3 was expressed on the multinucleated osteoclasts which were positive for tartrate-resistant acid phosphatase (TRAP), but not on mononuclear TRAP-positive cells. The Tyro 3 ligand, Gas6, induced the phosphorylation of Tyro 3 receptors in osteoclasts in two to five min. Gas6 and protein S directly enhanced the bone resorbing activity of mature osteoclasts. This effect of Gas6 was inhibited by the addition of a tyrosine kinase inhibitor, herbimycin A. However, Gas6 did not affect the differentiation of osteoclasts from bone marrow cells. Gas6 and protein S are dependent on vitamin K, a cofactor for the enzyme responsible for carboxylation of glutamic acid residues. The findings in this study are the first to indicate a new biological activity of Gas6 and protein S as a direct regulator of osteoclastic function; they give an insight into the role of these vitamin K-dependent ligands in bone resorption in vivo.
This article has been cited by other articles:
![]() |
T. Morgan, G. J. Atkins, M. K. Trivett, S. A. Johnson, M. Kansara, S. L. Schlicht, J. L. Slavin, P. Simmons, I. Dickinson, G. Powell, et al. Molecular Profiling of Giant Cell Tumor of Bone and the Osteoclastic Localization of Ligand for Receptor Activator of Nuclear Factor {kappa}B Am. J. Pathol., July 1, 2005; 167(1): 117 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bern Observations on Possible Effects of Daily Vitamin K Replacement, Especially Upon Warfarin Therapy JPEN J Parenter Enteral Nutr, November 1, 2004; 28(6): 388 - 398. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Hasanbasic, J. Cuerquis, B. Varnum, and M. D. Blostein Intracellular signaling pathways involved in Gas6-Axl-mediated survival of endothelial cells Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1207 - H1213. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Benzakour and C. Kanthou The anticoagulant factor, protein S, is produced by cultured human vascular smooth muscle cells and its expression is up-regulated by thrombin Blood, March 15, 2000; 95(6): 2008 - 2014. [Abstract] [Full Text] [PDF] |
||||
![]() |
J T Merrill and R G Lahita Sex hormone binding globulins and atherosclerotic risk in systemic lupus Lupus, March 1, 2000; 9(3): 217 - 222. [Abstract] [PDF] |
||||
![]() |
Z. Lan, H. Wu, W. Li, S. Wu, L. Lu, M. Xu, and W. Dai Transforming activity of receptor tyrosine kinase Tyro3 is mediated, at least in part, by the PI3 kinase-signaling pathway Blood, January 15, 2000; 95(2): 633 - 638. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Huber, K. W. Davidson, M. E. O'Brien-Morse, and J. A. Sadowski Tissue Phylloquinone and Menaquinones in Rats Are Affected by Age and Gender J. Nutr., May 1, 1999; 129(5): 1039 - 1044. [Abstract] [Full Text] |
||||
![]() |
K. O'Donnell, I. C. Harkes, L. Dougherty, and I. P. Wicks Expression of Receptor Tyrosine Kinase Axl and its Ligand Gas6 in Rheumatoid Arthritis : Evidence for a Novel Endothelial Cell Survival Pathway Am. J. Pathol., April 1, 1999; 154(4): 1171 - 1180. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chikazu, Y. Hakeda, N. Ogata, K. Nemoto, A. Itabashi, T. Takato, M. Kumegawa, K. Nakamura, and H. Kawaguchi Fibroblast Growth Factor (FGF)-2 Directly Stimulates Mature Osteoclast Function through Activation of FGF Receptor 1 and p42/p44 MAP Kinase J. Biol. Chem., September 29, 2000; 275(40): 31444 - 31450. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
